MedTrace Logo

Clinical Use Study of SAPH Device for Patent Hemostasis After a Transradial Procedure

NCT06991010 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-07-15

No results posted yet for this study

Summary

This is a prospective, multicenter study intended to provide supportive clinical information on the use of the SAPH device to achieve radial artery patent hemostasis after a transradial procedure.

Conditions

  • Hemostasis of Arterial Punctures

Interventions

DEVICE

Suction-Activated Patent Hemostasis (SAPH) Device

A compression device intended to achieve patient hemostasis of the radial artery

Sponsors & Collaborators

  • RARAS CRO

    collaborator UNKNOWN

  • Transradial Technologies, LLC

    lead INDUSTRY

Principal Investigators

  • Regulatory and Clinical Lead, PhD · Transradial Technologies, LLC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-01
Primary Completion
2025-10-28
Completion
2025-11-28
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06991010 on ClinicalTrials.gov